Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ida R. Marlet"'
Autor:
Joakim Ölmestig, Ida R. Marlet, Tina Vilsbøll, Jørgen Rungby, Egill Rostrup, Kate L. Lambertsen, Christina Kruuse
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
Background and aimsGlucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1RA) are widely used for the treatment of type 2 diabetes, and recent studies indicate that they may be cardio- and neuroprotective. The safety and effect of a single dose of e
Externí odkaz:
https://doaj.org/article/0508ac5eafc248868ad0a6b555708e62
Autor:
Egill Rostrup, Rasmus Hvass Hansen, Kate Lykke Lambertsen, Rikke Steen Krawcyk, Christina Kruuse, Shazia Rehman, Joakim N.E. Ölmestig, Ida R. Marlet
Publikováno v:
ölmestig, J, Marlet, I R, Hansen, R H, Rehman, S, Krawcyk, R S, Rostrup, E, Lambertsen, K L & Kruuse, C 2020, ' Tadalafil may improve cerebral perfusion in small-vessel occlusion stroke-a pilot study ', Brain Communications, vol. 2, no. 1 . https://doi.org/10.1093/braincomms/fcaa020
Ölmestig, J, Marlet, I R, Hansen, R H, Rehman, S, Krawcyk, R S, Rostrup, E, Lambertsen, K L & Kruuse, C 2020, ' Tadalafil may improve cerebral perfusion in small-vessel occlusion stroke-a pilot study ', Brain Communications, vol. 2, no. 1, pp. fcaa020 . https://doi.org/10.1093/braincomms/fcaa020
Brain Communications
Ölmestig, J, Marlet, I R, Hansen, R H, Rehman, S, Krawcyk, R S, Rostrup, E, Lambertsen, K L & Kruuse, C 2020, ' Tadalafil may improve cerebral perfusion in small-vessel occlusion stroke-a pilot study ', Brain Communications, vol. 2, no. 1, pp. fcaa020 . https://doi.org/10.1093/braincomms/fcaa020
Brain Communications
New treatments for cerebral small-vessel disease are needed to reduce the risk of small-vessel occlusion stroke and vascular cognitive impairment. We investigated an approach targeted to the signalling molecule cyclic guanosine monophosphate, using t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056d91f0403064ef9822653b8639f4ec
https://findresearcher.sdu.dk:8443/ws/files/170737955/fcaa020.pdf
https://findresearcher.sdu.dk:8443/ws/files/170737955/fcaa020.pdf
Publikováno v:
Marlet, I R, Ölmestig, J N E, Vilsbøll, T, Rungby, J & Kruuse, C 2018, ' Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke : A Systematic Review based on Pre-Clinical Studies ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 6, pp. 559-569 . https://doi.org/10.1111/bcpt.12974
Glucagon-like peptide-1 (GLP-1)-based therapies, GLP-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase-4 inhibitors (DPP-4Is) are widely used for the treatment of type 2 diabetes. Increasing evidence suggests that they may provide neuroprotecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b159c8c18f32ba5f139c3dd1c65cb3fd
https://pure.au.dk/portal/da/publications/neuroprotective-mechanisms-of-glucagonlike-peptide1based-therapies-in-ischaemic-stroke(36e2ce48-9ec5-4fe0-8a7a-2c8370e5030d).html
https://pure.au.dk/portal/da/publications/neuroprotective-mechanisms-of-glucagonlike-peptide1based-therapies-in-ischaemic-stroke(36e2ce48-9ec5-4fe0-8a7a-2c8370e5030d).html
Publikováno v:
Cellular signalling. 38
Phosphodiesterase 5 inhibitors (PDE5i), such as sildenafil (Viagra®) are widely used for erectile dysfunction and pulmonary hypertension. Preclinical studies suggest that PDE5i may improve functional outcome following ischemic stroke. In this system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de98d5255936da887282728f90671dd3
https://pubmed.ncbi.nlm.nih.gov/28648945
https://pubmed.ncbi.nlm.nih.gov/28648945
Autor:
Marlet, Ida R.1, Ölmestig, Joakim N. E.1, Vilsbøll, Tina2,3, Rungby, Jørgen4, Kruuse, Christina1,3 ckruuse@dadlnet.dk
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. Jun2018, Vol. 122 Issue 6, p559-569. 11p.